Pending AI
1 known investors
Pending AI develops a computational drug discovery platform that combines quantum mechanics and artificial intelligence to model protein structures and design drug candidates. It targets pharmaceutical and therapeutic development, including historically difficult-to-drug targets, by optimizing drug profiles before synthesis.
Investors · 1
Frequently asked questions
- What does Pending AI do?
- Pending AI develops a computational drug discovery platform that combines quantum mechanics and artificial intelligence to model protein structures and design drug candidates. It targets pharmaceutical and therapeutic development, including historically difficult-to-drug targets, by optimizing drug profiles before synthesis.
- Who are Pending AI's investors?
- Pending AI's investors include Main Sequence Ventures.